[January 24, 2018] |
|
Genedata, HighRes Biosolutions, and Titian Software Collaborate for Automated End-to-End Screening Solution
Genedata,
HighRes
Biosolutions, and Titian
Software announce a partnership integrating their flagship products
into a seamless solution that automates iterative drug discovery
processes for designing and planning, testing, and data analysis. The
approach offers a streamlined workflow from sample logistics to
automation to analysis and back, effortlessly moving information to
where it is needed and ultimately providing researchers with the time
and freedom to focus on their science. This industry-first integration,
which brings real-time data analysis and heightened efficiencies to
screening labs, will be showcased by the three partners at SLAS2018 (Feb
3-7, San Diego Convention Center).
This press release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20180124005019/en/
"Our partnership brings together best-in-class solutions relied on by
the world's leading pharmaceutical and biopharmaceutical companies and
CROs," said Edmund Wilson, CEO of Titian Software. "Moreover, we are
empowering researchers to quickly and easily perform complex informatics
workflows, which typically span many departments and informatics
resources."
The partnership builds on collaborations in which HighRes and Titian
connected Cellario and Mosaic
to automatically interpret and produce Mosaic-defined work, replication,
jobs, etc. Titian and Genedata integrated Mosaic with Genedata
Screener® to automatically retrieve assay plate sample
data from Mosaic. Most recently, Cellario was integrated with Genedata
Screener for real-time data analysis of Cellario
experiment results. The integration of all three solutions effectively
closes the loop on logstics, production, and data analysis.
Advancing Laboratory Automation With the solutions'
integration, screening scientists can now design and order assay plates
in the Titian Mosaic sample management software, accept and run the
fully automated screening process on the HighRes automated system, and
trigger the automated data analysis and approval in Genedata Screener.
This highly automated workflow allows scientists to step away from
tedious manual tasks, decreases the potential for errors, and removes
bottlenecks. Delivering a new level of laboratory automation, the
integration is inherently flexible and significantly improves the
efficiency of research processes while providing a full audit trail for
data, samples and operations.
"A major advantage for us is the way we feed parameters from Mosaic
orders to customize the protocol for the task at hand automatically,"
noted Ira Hoffman (News - Alert), president of HighRes Biosolutions. "This greatly
simplifies an operator's job. Our customers have been able to reduce the
number of different protocols from more than 200 to fewer than 10, which
demonstrates the significant time savings and overall improvement in
operational efficiency for our shared compound management customers."
"Genedata is committed to transformative industry collaborations that
automate workflows and optimize the drug discovery process," said Dr.
Othmar Pfannes, CEO of Genedata. "Our partnership with HighRes and
Titian, industry leaders in experiment automation and sample storage,
delivers on that commitment by enabling an out-of-the-box solution for
the complete screening process."
Editorial Note: The partners will demonstrate their
combined screening solution at the SLAS2018
conference in San Diego. Their tutorial "Partnering to Close the
Screening Loop: From Sample Logistics to Automation to Analysis and
Back," will be held on Feb. 6 at 2pm in Room 2.
The Partners
About Genedata Genedata transforms data into intelligence
with innovative software solutions and domain-specific consulting
services that automate complex, large-scale experimental processes and
enable organizations to maximize the ROI from their R&D. Founded in
1997, Genedata is headquartered in Switzerland and has offices in
Germany, the UK, Japan, and the US. Visit www.genedata.com
or follow Genedata
on LinkedIn.
About HighRes Biosolutions HighRes Biosolutions improves
human health through life science robotics. The company designs and
builds innovative laboratory automation systems, dynamic scheduling
software, and lab automation instruments that accelerate and streamline
discovery. HighRes offers highly flexible, modular solutions that
provide its clients with the ability to scale and reconfigure their
automation equipment as their assays or technology changes. Visit www.highresbio.com
or follow HighResBio
on LinkedIn.
About Titian Software Founded in 1999, Titian Software
supplies software and consultancy to improve sample management and
inventory logistics for life science research. Mosaic is Titian's
customizable, modular software to control and monitor all aspects of
sample storage and preparation for compounds, reagents and biologics.
Companies worldwide, from small biotech to global pharma, trust Mosaic
to provide a seamless, error-free sample supply chain. SampleBank and
FreezerManagement provide optimized and pre-configured subsets of Mosaic
available for rapid deployment. Visit www.titian.co.uk
or follow Titian
on LinkedIn.
Disclaimer The statements in this press release that relate
to future plans, events or performance are forward-looking statements
that involve risks and uncertainties, including risks associated with
uncertainties related to contract cancellations, developing risks,
competitive factors, uncertainties pertaining to customer orders, demand
for products and services, development of markets for each Company's
products and services. Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the date
hereof. The Companies undertake no obligation to release publicly the
result of any revisions to these forward-looking statements that may be
made to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their
respective companies.
###
View source version on businesswire.com: http://www.businesswire.com/news/home/20180124005019/en/
[ Back To TMCnet.com's Homepage ]
|